{"id":4588,"date":"2020-05-28T11:01:14","date_gmt":"2020-05-28T09:01:14","guid":{"rendered":"https:\/\/irlab.se\/?page_id=4588"},"modified":"2022-02-07T14:38:08","modified_gmt":"2022-02-07T13:38:08","slug":"valberedning-infor-arsstamma-2020","status":"publish","type":"page","link":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/","title":{"rendered":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\" id=\"valberedning-infor-arsstamma-2021\">Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021<\/h1>\n\n\n\n<p>Inf\u00f6r \u00e5rsst\u00e4mman 2021 har de tre st\u00f6rsta \u00e4garna eller \u00e4gargrupperna utsett sina representanter f\u00f6r valberedningen. Valberedningen best\u00e5r av f\u00f6ljande ledam\u00f6ter:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Daniel Johnsson, valberedningens ordf\u00f6rande, entrepren\u00f6r, bolagsutvecklare och investerare, utsedd av en \u00e4gargrupp som representerar cirka 23 procent av aktier och r\u00f6ster;<\/li><li>Bo Rydlinger, bakgrund fr\u00e5n bank- och investeringsverksamhet, utsedd av en \u00e4gargrupp som representerar cirka 19 procent av aktier och r\u00f6ster;<\/li><li>Clas Sonesson, forskningschef (CSO) p\u00e5 IRLAB och en av IRLAB:s grundare. Utsedd av en \u00e4gargrupp best\u00e5ende av bolagets grundare som representerar cirka 11 procent av aktier och r\u00f6ster; samt<\/li><li>Gunnar Olsson, styrelseordf\u00f6rande i IRLAB Therapeutics AB.<\/li><\/ul>\n\n\n\n<p>Valberedningens f\u00f6rslag kommer att presenteras i kallelsen till \u00e5rsst\u00e4mman 2021 och p\u00e5 bolagets webplats &#8211; irlab.se.<\/p>\n\n\n\n<p>Aktie\u00e4gare som vill l\u00e4mna f\u00f6rslag till valberedningen kan kontakta valberedningen p\u00e5 bolagets adress eller e-post \u2013 info@irlab.se. F\u00f6r att ge valberedningen m\u00f6jlighet att beakta ett f\u00f6rslag m\u00e5ste det ha inkommit till valberedningen i god tid f\u00f6re \u00e5rsst\u00e4mman, dock senast den 31 januari 2021.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 Inf\u00f6r \u00e5rsst\u00e4mman 2021 har de tre st\u00f6rsta \u00e4garna eller \u00e4gargrupperna utsett sina representanter f\u00f6r valberedningen. Valberedningen best\u00e5r av f\u00f6ljande ledam\u00f6ter: Daniel Johnsson, valberedningens ordf\u00f6rande, entrepren\u00f6r, bolagsutvecklare och investerare, utsedd av en \u00e4gargrupp som representerar cirka 23 procent av aktier och r\u00f6ster; Bo Rydlinger, bakgrund fr\u00e5n bank- och investeringsverksamhet, utsedd av en [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2554,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4588","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 Inf\u00f6r \u00e5rsst\u00e4mman 2021 har de tre st\u00f6rsta \u00e4garna eller \u00e4gargrupperna utsett sina representanter f\u00f6r valberedningen. Valberedningen best\u00e5r av f\u00f6ljande ledam\u00f6ter: Daniel Johnsson, valberedningens ordf\u00f6rande, entrepren\u00f6r, bolagsutvecklare och investerare, utsedd av en \u00e4gargrupp som representerar cirka 23 procent av aktier och r\u00f6ster; Bo Rydlinger, bakgrund fr\u00e5n bank- och investeringsverksamhet, utsedd av en [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-07T13:38:08+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/\",\"url\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/\",\"name\":\"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2020-05-28T09:01:14+00:00\",\"dateModified\":\"2022-02-07T13:38:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bolagsstyrning\",\"item\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Valberedning\",\"item\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"F\u00f6reg\u00e5ende valberedningar\",\"item\":\"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/","og_locale":"sv_SE","og_type":"article","og_title":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 - IRLAB","og_description":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 Inf\u00f6r \u00e5rsst\u00e4mman 2021 har de tre st\u00f6rsta \u00e4garna eller \u00e4gargrupperna utsett sina representanter f\u00f6r valberedningen. Valberedningen best\u00e5r av f\u00f6ljande ledam\u00f6ter: Daniel Johnsson, valberedningens ordf\u00f6rande, entrepren\u00f6r, bolagsutvecklare och investerare, utsedd av en \u00e4gargrupp som representerar cirka 23 procent av aktier och r\u00f6ster; Bo Rydlinger, bakgrund fr\u00e5n bank- och investeringsverksamhet, utsedd av en [&hellip;]","og_url":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/","og_site_name":"IRLAB","article_modified_time":"2022-02-07T13:38:08+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/","url":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/","name":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2020-05-28T09:01:14+00:00","dateModified":"2022-02-07T13:38:08+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/valberedning-infor-arsstamma-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Bolagsstyrning","item":"https:\/\/irlab.se\/sv\/bolagsstyrning\/"},{"@type":"ListItem","position":3,"name":"Valberedning","item":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/"},{"@type":"ListItem","position":4,"name":"F\u00f6reg\u00e5ende valberedningar","item":"https:\/\/irlab.se\/sv\/bolagsstyrning\/nomination-committee\/nomination-committees\/"},{"@type":"ListItem","position":5,"name":"Valberedning inf\u00f6r \u00e5rsst\u00e4mma 2021"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/4588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=4588"}],"version-history":[{"count":6,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/4588\/revisions"}],"predecessor-version":[{"id":7308,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/4588\/revisions\/7308"}],"up":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/2554"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=4588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}